Publications by Hans Petter Gullestad
16 publications found
Original articles
Survival after lymphadenectomy of nodal metastases from melanoma of unknown primary site
J Plast Surg Hand Surg, 57 (1-6), 109-114
DOI 10.1080/2000656X.2021.2010739, PubMed 34878354
Late arm and shoulder problems after axillary therapeutic lymph node dissection in patients with melanoma
J Plast Surg Hand Surg, 55 (2), 127-131
DOI 10.1080/2000656X.2020.1842746, PubMed 33176535
Targeting AXL and the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Melanoma
Mol Cancer Ther, 19 (3), 895-905
DOI 10.1158/1535-7163.MCT-19-0290, PubMed 31871265
2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: long-term follow-up of a multicentre, randomised trial
Lancet, 394 (10197), 471-477
DOI 10.1016/S0140-6736(19)31132-8, PubMed 31280965
A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases
Transl Oncol, 12 (7), 951-958
DOI 10.1016/j.tranon.2019.04.001, PubMed 31096111
Beyond total mesorectal excision in locally advanced rectal cancer with organ or pelvic side-wall involvement
Eur J Surg Oncol, 44 (8), 1226-1232
DOI 10.1016/j.ejso.2018.03.029, PubMed 29691115
Vertical Rectus Abdominis Musculocutaneous Flap Repair Improves Perineal Wound Healing after Abdominoperineal Resection for Irradiated Locally Advanced Rectal Cancer
Ann Surg Oncol, 25 (5), 1357-1365
DOI 10.1245/s10434-018-6363-3, PubMed 29497909
Human Adipose-Derived Mesenchymal Stem Cells Respond to Short-Term Hypoxia by Secreting Factors Beneficial for Human Islets In Vitro and Potentiate Antidiabetic Effect In Vivo
Cell Med, 9 (3), 103-116
DOI 10.3727/215517917X693401, PubMed 28713640
Risk reducing mastectomy, breast reconstruction and patient satisfaction in Norwegian BRCA1/2 mutation carriers
Breast, 23 (1), 38-43
DOI 10.1016/j.breast.2013.10.002, PubMed 24210736
2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial
Lancet, 378 (9803), 1635-42
DOI 10.1016/S0140-6736(11)61546-8, PubMed 22027547
Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA
Cancer Gene Ther, 13 (10), 905-18
DOI 10.1038/sj.cgt.7700961, PubMed 16710345
Nonrandom numerical chromosome abnormalities in basal cell carcinomas
Cancer Genet Cytogenet, 103 (1), 35-42
DOI 10.1016/s0165-4608(97)00356-7, PubMed 9595042
The reciprocal translocation t(9;16)(q22;p13) is a primary chromosome abnormality in basal cell carcinomas
Cancer Res, 57 (3), 404-6
PubMed 9012465
Breath methane and colorectal cancer
Scand J Gastroenterol, 27 (1), 25-8
DOI 10.3109/00365529209011161, PubMed 1736338
Other articles
Human malignant melanoma harbours a large fraction of highly clonogenic cells that do not express markers associated with cancer stem cells
Pigment Cell Melanoma Res, 23 (3), 449-51
DOI 10.1111/j.1755-148X.2010.00690.x, PubMed 20236249
Tissue expansion for the treatment of myelomeningocele. Case report
Scand J Plast Reconstr Surg Hand Surg, 27 (2), 149-51
DOI 10.3109/02844319309079799, PubMed 8351497